Feasibility and Tolerability of Arterial Infusion Chemotherapy and Embolization for Recurrent/Metastatic Soft Tissue Sarcoma: A Retrospective Exploratory Study
AICE might be a feasible and well-tolerated treatment for recurrent/metastatic STS, effectively controlling disease progression and improving survival outcomes in this retrospective cohort. Further multicenter, large-scale prospective studies were needed to validate these findings and explore the combination of AICE with immunotherapy or targeted therapy to optimize treatment strategy for STS.
Authors
- Maoqiang Wang (ORCID: https://orcid.org/0000-0002-0299-5289)
- D Y Wang
- Jiemin Zhou (ORCID: https://orcid.org/0000-0001-6317-5973)
- Jing Li (ORCID: https://orcid.org/0000-0002-0079-693X)
- Rui Liu (ORCID: https://orcid.org/0000-0002-0549-3532)
- Baorang Zhu
- Wuwei Yang (ORCID: https://orcid.org/0000-0002-6001-096X)
Institutions
- Chinese PLA General Hospital (CN)
- Aerospace Center Hospital (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/dddt.s538212
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00